Halozyme Therapeutics, Inc.
A San Diego biopharma company whose ENHANZE technology uses a naturally occurring enzyme to temporarily loosen the gel-like tissue under the skin, letting large-volume biologic medicines be injected in minutes instead of slowly dripped over hours. Its partners sell drugs built on this platform, such as DARZALEX FASPRO and HYQVIA, and it also makes auto-injector devices and its own products like XYOSTED. Co-founded in 1998 by Dr. Gregory Frost, the company's name blends "hyaluronidase" and "enzyme" — the very molecule its science revolves around.
Granted 1.16M · Sold 766.6K
Granted 6.5K
Granted 324.4K · Sold 271.7K
Granted 14.5K · Sold 49.9K
Granted 96.1K
Granted 17.5K · Sold 14.1K
Granted 133.2K · Sold 57.2K
Granted 14.5K · Sold 25.0K
Granted 10.7K
Granted 14.5K
Granted 33.5K · Sold 33.1K
Granted 21.8K · Sold 7.3K
Granted 4.7K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Torley HelenPRESIDENT AND CEO, Director · 187 transactions | +24.1% | 773.9K | 1.16M | — | 766.6K |
| Matsui ConnieDirector · 2 transactions | -2.1% | 183.0Kas of Nov 2024 | 6.5K | — | — |
| LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER · 91 transactions | +14.4% | 173.8Kas of Feb 2025 | 324.4K | — | 271.7K |
| Posard Matthew L.Director · 8 transactions | -31.3% | 77.8K | 14.5K | — | 49.9K |
| Snyder Mark HowardSVP, CHIEF LEGAL OFFICER · 26 transactions | +995.2% | 52.6K | 96.1K | — | — |
| Connaughton BernadetteDirector · 13 transactions | +8.4% | 43.7K | 17.5K | — | 14.1K |
| LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICER · 44 transactions | +263.2% | 42.1K | 133.2K | — | 57.2K |
| Henderson Jeffrey WilliamDirector · 11 transactions | -22.4% | 36.6K | 14.5K | — | 25.0K |
| Miyashita Akiko MoniDirector · 2 transactions | +74.7% | 24.9Kas of May 2025 | 10.7K | — | — |
| Duncan Barbara GayleDirector · 3 transactions | +156.3% | 23.7K | 14.5K | — | — |
| Caudill CortneySVP, CHIEF OPERATING OFFICER · 9 transactions | — | 15.9K | 33.5K | — | 33.1K |
| Krishnan MaheshDirector · 5 transactions | — | 14.5K | 21.8K | — | 7.3K |
| Lang James PaulDirector · 2 transactions | — | 4.7K | 4.7K | — | — |
Select a row to see that insider’s individual transactions.
Net open-market activity over the last 3 years: -1.22M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.